Waypoint Bio
Latest round
- Series A
Last raised
- May 2026
Total raised
- $35M
Investors
- 8
About Waypoint Bio
Established in 2021 by Xinchen Wang (CEO) and David Phizicky (CSO), and based in New York, US, Waypoint Bio operates as a developer of tumor cell therapies that focus on cancer and autoimmune diseases using in vivo testing. In May 2026, Waypoint Bio, Inc. Waypoint Bio develops and offers cell therapy design and development with a platform that provides high-throughput, high-dimensional multiplexing screens that leverage spatial biology technology to measure cell-autonomous and non-autonomous effects. Utilizing advances in computer vision, in silico protein design, and pooled screening, Waypoint achieves deep phenotyping and optimized cell therapy selection to create novel cell therapies for solid tumors and autoimmune diseases.
Who invested in Waypoint Bio
8 investors across 2 rounds
See all investors in Waypoint Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Waypoint Bio
Who invested in Waypoint Bio?
Waypoint Bio has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Waypoint Bio raised?
Waypoint Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Waypoint Bio last raise money?
Waypoint Bio's most recent round on record is a Series A, in May 2026.
What does Waypoint Bio do?
Established in 2021 by Xinchen Wang (CEO) and David Phizicky (CSO), and based in New York, US, Waypoint Bio operates as a developer of tumor cell therapies that focus on cancer and autoimmune diseases using in vivo testing.
Where is Waypoint Bio headquartered?
Waypoint Bio is headquartered in New York, US.
Which VCs invest in companies like Waypoint Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Waypoint Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Waypoint Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.